Daigo Akahane
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Sustained molecular response after discontinuation of ropeginterferon alfa-2b in a young patient with polycythemia vera
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 29, 2026
Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells.
Journal: Anticancer research
Published: December 24, 2025
Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling study.
Journal: Leukemia research
Published: December 21, 2025
Reciprocal Clonal Dynamics of Independent FLT3 D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With Gilteritinib.
Journal: EJHaem
Published: November 27, 2025
Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell Lines.
Journal: Journal of cellular and molecular medicine
Published: November 06, 2025
Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells.
Journal: Hematology reports
Published: October 22, 2025
Aplastic anaemia with small paroxysmal nocturnal haemoglobinuria clones developing during osimertinib therapy for non-small cell lung cancer.
Journal: Leukemia research reports
Published: October 19, 2025
Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3.
Journal: International journal of hematology
Published: July 28, 2025
Subcutaneous epcoritamab monotherapy in Japanese patients with relapsed or refractory follicular lymphoma: primary results of the EPCORE NHL-3 trial.
Journal: Leukemia & lymphoma
Published: July 09, 2025
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial.
Journal: International journal of clinical oncology
Published: March 13, 2025
Comparison of IPSS-R and IPSS-M in newly diagnosed myelodysplastic neoplasms: a single-center study
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: February 09, 2025
Last Updated: 09/26/2026